Grifols (GRFS) Operating Expenses (2010 - 2023)
Grifols' (GRFS) quarterly Operating Expenses came in at $171022.8 in Q4 2023, up 364.68% YoY from $36804.4 in Q4 2022, and up 364.68% on a QoQ basis from $36804.4 in Q4 2022.
Grifols (GRFS) Operating Expenses (2010 - 2023) Analysis & Trends
Grifols (GRFS) has 13 years of Operating Expenses data on file, last reported at $171022.8 in Q4 2023.
- Quarterly Operating Expenses rose 364.68% year-over-year to $171022.8 in Q4 2023, while the trailing twelve-month figure through Dec 2025 was $207827.2 (changed 0.0% YoY) and the FY2025 annual result came in at $1.9 billion, up 6.94% from the prior year.
- Operating Expenses grew to $171022.8 in Q4 2023, from $36804.4 in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $171022.8 in Q4 2023 to a low of -$993.1 million in Q4 2019.
- A 4-year average of -$336.4 million and a median of -$337.5 million in 2019 frame the typical range for Operating Expenses.
- Annual changes were most pronounced in 2019 — Operating Expenses slipped 14.7% — and 2023, when it soared 364.68%.
- Tracing GRFS's Operating Expenses over 4 years: stood at -$993.1 million in 2019, then soared by 64.6% to -$351.5 million in 2020, then soared by 100.01% to $36804.4 in 2022, then soared by 364.68% to $171022.8 in 2023.
- The last three Operating Expenses figures came in at $171022.8 (Q4 2023), $36804.4 (Q4 2022), and -$351.5 million (Q1 2020), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 10.12 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 10.56 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 12.80 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 6.09 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 9.70 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 6.54 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 18.20 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | 6.68 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | -7.60 Bn |
| 10 | Grifols | 5.45 Bn | 4.45 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 171,022.80 |
| Dec 31, 2022 | 36,804.40 |
| Mar 31, 2020 | -351.55 Mn |
| Dec 31, 2019 | -993.06 Mn |
| Mar 31, 2019 | -337.55 Mn |
| Dec 31, 2018 | -865.76 Mn |
| Jun 30, 2018 | 305.20 Mn |
| Mar 31, 2018 | -300.11 Mn |
| Dec 31, 2017 | -979.68 Mn |
| Jun 30, 2017 | 303.67 Mn |
| Mar 31, 2017 | -308.10 Mn |
| Dec 31, 2016 | 1.83 Bn |
| Sep 30, 2016 | 254.98 Mn |
| Jun 30, 2016 | 278.46 Mn |
| Dec 31, 2015 | 295.12 Mn |
| Sep 30, 2015 | 261.68 Mn |
| Jun 30, 2015 | 266.77 Mn |
| Mar 31, 2015 | -242.62 Mn |
| Dec 31, 2014 | 270.43 Mn |
| Sep 30, 2014 | 282.82 Mn |